The Effect Of Methotrexate On Adalimumab Pharmacokinetics: Pooled Analysis Of Adalimumab Pharmacokinetics In Patients With Rheumatoid Arthritis After Subcutaneous Administration.

被引：0
|
作者：
Awni, Walid [1 ]
Pilari, Sabine [2 ]
Ahmed, Ghada [1 ]
Noertersheuser, Peter [2 ]
机构：
[1] AbbVie Inc, N Chicago, IL USA
[2] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
488
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [31] Oral Tuberculosis in a Patient With Rheumatoid Arthritis After Long Treatment With Methotrexate and Adalimumab
    Barouta, Georgia
    Karapetsa, Maria
    Kostopoulou, Evanthia
    Alexiou, Ioannis
    Koukoulis, Georgios
    Sakkas, Lazaros I.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (07) : 330 - 331
  • [32] Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy
    Baraldo, M
    Ferraccioli, G
    Pea, F
    Gremese, E
    Furlanut, M
    PHARMACOLOGICAL RESEARCH, 1999, 40 (06) : 483 - 486
  • [33] Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis
    Lee, Young Ho
    Song, Gwan Gyu
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (01): : 64 - 70
  • [34] The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease
    Matucci-Cerinic, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (01) : 34 - 35
  • [35] Effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis
    Schwartz, J. I.
    Agrawal, N. G. B.
    Wong, P. H.
    Miller, J. L.
    Mehta, A.
    Bachmann, K.
    Marbury, T.
    Hoelscher, D.
    Gottesdiener, K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1127 - 1127
  • [36] THE EFFECT OF SUBCUTANEOUS (SC) METHOTREXATE (MTX) AND ADALIMUMAB (ADA) ON CYTOKINE PROFILE IN MTX-NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (RA)
    Avdeeva, A. S.
    Novikov, A. A.
    Aleksandrova, E. N.
    Karateev, D. E.
    Luchihina, E. L.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 215 - 216
  • [37] Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
    Tomoyuki Imagawa
    Syuji Takei
    Hiroaki Umebayashi
    Kenichi Yamaguchi
    Yasuhiko Itoh
    Toshinao Kawai
    Naomi Iwata
    Takuji Murata
    Ikuo Okafuji
    Mari Miyoshi
    Yasuhiro Onoe
    Yoshifumi Kawano
    Noriko Kinjo
    Masaaki Mori
    Neelufar Mozaffarian
    Hartmut Kupper
    Sourav Santra
    Gina Patel
    Shinichi Kawai
    Shumpei Yokota
    Clinical Rheumatology, 2012, 31 : 1713 - 1721
  • [38] Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
    Imagawa, Tomoyuki
    Takei, Syuji
    Umebayashi, Hiroaki
    Yamaguchi, Kenichi
    Itoh, Yasuhiko
    Kawai, Toshinao
    Iwata, Naomi
    Murata, Takuji
    Okafuji, Ikuo
    Miyoshi, Mari
    Onoe, Yasuhiro
    Kawano, Yoshifumi
    Kinjo, Noriko
    Mori, Masaaki
    Mozaffarian, Neelufar
    Kupper, Hartmut
    Santra, Sourav
    Patel, Gina
    Kawai, Shinichi
    Yokota, Shumpei
    CLINICAL RHEUMATOLOGY, 2012, 31 (12) : 1713 - 1721
  • [39] Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients
    Hartmann, SN
    Rordorf, CM
    Milosavljev, S
    Branson, JM
    Chales, GH
    Juvin, RR
    Lafforgue, P
    Le Parc, JM
    Tavernier, CG
    Meyer, OC
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) : 1582 - 1587
  • [40] Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis
    Zhou, HH
    Mayer, PR
    Wajdula, J
    Fatenejad, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (11): : 1235 - 1243
12345